| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.006 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.006 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.094 | 0.006 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.009 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.098 | 0.009 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |